# SBC Medical Group Holdings Inc: filings

SBC · Nasdaq · CIK 1930313 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbc.md) · [Financials](/companies/sbc/financials.md) · [Filings](/companies/sbc/filings.md) · [Insiders](/companies/sbc/insiders.md)

## Reports and events: 86 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 46, 4 37, DEFA14A 20, 3 16, 10-Q 13, CORRESP 11, UPLOAD 10, 424B3 8, SC 13D/A 8, PRER14A 7, SC 13G 6, SC 13G/A 6, 10-K 4, DEF 14A 4, EFFECT 4, PRE 14A 4, 10-K/A 3, 424B7 2, NT 10-Q 2, S-1 2, S-1/A 2, SC 13D 2, SCHEDULE 13D/A 2, 25-NSE 1, 3/A 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, DEFM14A 1, DRS 1, POS AM 1, POS EX 1, PREM14A 1, S-3 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 07:00 ET | [10-Q](/filings/0001193125-26-347843.md) | Quarterly report, period 2026-06-30 | 0001193125-26-347843 |
| 2026-08-13 | 06:50 ET | [8-K](/filings/0001193125-26-347825.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347825 |
| 2026-07-14 | 17:00 ET | [8-K](/filings/0001493152-26-033195.md) | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-033195 |
| 2026-05-28 | 06:09 ET | [DEF 14A](/filings/0001493152-26-025514.md) | Proxy statement, period 2026-05-28 | 0001493152-26-025514 |
| 2026-05-20 | 16:15 ET | [8-K](/filings/0001493152-26-024609.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-024609 |
| 2026-05-14 | 07:00 ET | [10-Q](/filings/0001193125-26-222737.md) | Quarterly report, period 2026-03-31 | 0001193125-26-222737 |
| 2026-05-14 | 06:50 ET | [8-K](/filings/0001193125-26-222720.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-222720 |
| 2026-04-30 | 17:21 ET | [10-K/A](/filings/0001493152-26-020748.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-020748 |
| 2026-04-23 | 20:48 ET | [8-K](/filings/0001493152-26-018603.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-018603 |
| 2026-04-21 | 21:07 ET | [SCHEDULE 13D/A](/filings/0001493152-26-018402.md) | Ownership report, active investor, amended | 0001493152-26-018402 |
| 2026-03-27 | 07:31 ET | [10-K](/filings/0001193125-26-127557.md) | Annual report, period 2025-12-31 | 0001193125-26-127557 |
| 2026-03-27 | 06:50 ET | [8-K](/filings/0001493152-26-013078.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013078 |
| 2026-03-10 | 21:53 ET | [SCHEDULE 13D/A](/filings/0001493152-26-009606.md) | Ownership report, active investor, amended | 0001493152-26-009606 |
| 2026-01-05 | 07:00 ET | [8-K](/filings/0001193125-26-001488.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-001488 |
| 2025-12-31 | 06:39 ET | [8-K](/filings/0001493152-25-029699.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029699 |
| 2025-12-15 | 06:01 ET | [8-K](/filings/0001193125-25-318331.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-318331 |
| 2025-11-14 | 07:00 ET | [10-Q](/filings/0001193125-25-281466.md) | Quarterly report, period 2025-09-30 | 0001193125-25-281466 |
| 2025-11-14 | 06:50 ET | [8-K](/filings/0001193125-25-281439.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281439 |
| 2025-11-13 | 06:02 ET | [8-K](/filings/0001193125-25-278669.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278669 |
| 2025-08-13 | 07:11 ET | [10-Q](/filings/0001641172-25-023322.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023322 |
| 2025-08-13 | 07:00 ET | [8-K](/filings/0001641172-25-023321.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023321 |
| 2025-07-17 | 08:05 ET | [8-K](/filings/0001641172-25-019984.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019984 |
| 2025-06-30 | 06:07 ET | [8-K](/filings/0001641172-25-017031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017031 |
| 2025-06-18 | 16:01 ET | [8-K](/filings/0001641172-25-015572.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015572 |
| 2025-05-28 | 06:07 ET | [DEF 14A](/filings/0001641172-25-012581.md) | Proxy statement, period 2025-05-28 | 0001641172-25-012581 |
| 2025-05-15 | 09:00 ET | [10-Q](/filings/0001641172-25-010567.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010567 |
| 2025-05-15 | 09:00 ET | [8-K](/filings/0001641172-25-010565.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010565 |
| 2025-05-09 | 08:33 ET | [10-K/A](/filings/0001641172-25-009366.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-009366 |
| 2025-04-30 | 16:22 ET | [10-K/A](/filings/0001641172-25-007813.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-007813 |
| 2025-04-02 | 16:15 ET | [8-K](/filings/0001641172-25-002370.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-002370 |
| 2025-03-28 | 09:12 ET | [10-K](/filings/0001641172-25-001062.md) | Annual report, period 2024-12-31 | 0001641172-25-001062 |
| 2025-03-28 | 07:45 ET | [8-K](/filings/0001641172-25-001050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001050 |
| 2025-02-18 | 06:01 ET | [8-K](/filings/0001493152-25-007047.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-007047 |
| 2024-12-20 | 09:00 ET | [8-K](/filings/0001493152-24-050895.md) | 7.01 Regulation FD disclosure | 0001493152-24-050895 |
| 2024-11-13 | 16:30 ET | [10-Q](/filings/0001493152-24-045154.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045154 |
| 2024-11-13 | 16:30 ET | [8-K](/filings/0001493152-24-045152.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045152 |
| 2024-10-08 | 09:58 ET | [S-1](/filings/0001213900-24-086109.md) | Registration statement | 0001213900-24-086109 |
| 2024-10-01 | 21:00 ET | [SC 13D/A](/filings/0001140361-24-042519.md) | Ownership report, active investor, amended | 0001140361-24-042519 |
| 2024-09-24 | 21:07 ET | [SC 13D/A](/filings/0001140361-24-041791.md) | Ownership report, active investor, amended | 0001140361-24-041791 |
| 2024-09-23 | 09:02 ET | [SC 13D/A](/filings/0001213900-24-080820.md) | Ownership report, active investor, amended | 0001213900-24-080820 |
| 2024-09-23 | 08:56 ET | [SC 13D](/filings/0001213900-24-080818.md) | Ownership report, active investor | 0001213900-24-080818 |
| 2024-09-20 | 16:05 ET | [8-K](/filings/0001213900-24-080668.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-080668 |
| 2024-09-19 | 20:13 ET | [SC 13D/A](/filings/0001140361-24-041494.md) | Ownership report, active investor, amended | 0001140361-24-041494 |
| 2024-08-29 | 06:05 ET | [8-K](/filings/0001493152-24-034279.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0001493152-24-034279 |
| 2024-08-23 | 17:43 ET | [8-K](/filings/0001493152-24-033614.md) | 7.01 Regulation FD disclosure | 0001493152-24-033614 |
| 2024-08-20 | 21:00 ET | [SC 13D/A](/filings/0001140361-24-037997.md) | Ownership report, active investor, amended | 0001140361-24-037997 |
| 2024-08-16 | 16:15 ET | [10-Q](/filings/0001213900-24-070251.md) | Quarterly report, period 2024-06-30 | 0001213900-24-070251 |
| 2024-08-12 | 09:08 ET | [8-K](/filings/0001493152-24-031176.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-031176 |
| 2024-07-26 | 21:02 ET | [SC 13D/A](/filings/0001140361-24-034470.md) | Ownership report, active investor, amended | 0001140361-24-034470 |
| 2024-05-20 | 16:17 ET | [10-Q](/filings/0001493152-24-020690.md) | Quarterly report, period 2024-03-31 | 0001493152-24-020690 |

Page 1 of 2. [Older](/companies/sbc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.